24
Pharmacological Treatment
Figure 4. BP Thresholds and Recommendations for
Treatment and Follow-Up
BP thresholds and recommendations for treatment and follow-up
Normal BP
(BP <120/
80 mm Hg)
NO YES
Elevated BP
(BP 120–129/
<80 mm Hg)
Stage 1
hypertension
(BP 130–139/
80–89 mm Hg)
Stage 2
hypertension
(BP ≥140/
90 mm Hg)
Reassess in 1 y
(Class IIa)
Reassess in
3–6 mo
(Class I)
Promote
optimal lifestyle
habits
Nonpharmacological
therapy
(Class I)
Nonpharmacological therapy
(Class I)
Nonpharmacological
therapy and BP-
lowering medication
(Class I)
Nonpharmacological
therapy and BP-
lowering medication
b
(Class I)
Reassess in 3–6 mo
(Class I)
Reassess in 1 mo
(Class I)
NO
YES
Assess and optimize
adherence to therapy
Consider intensification of
therapy
Reassess in 3–6 mo
(Class I)
BP goal
met
Clinical
ASCVD or
estimated 10-y
CVD risk
≥10%
a
